Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 10, 2025 in Regeneron Lawsuit - REGN
Portfolio Pulse from
Levi & Korsinsky has announced a lead plaintiff deadline of March 10, 2025, for a lawsuit involving Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN). Shareholders who suffered losses are encouraged to seek potential recovery under federal securities laws.
January 29, 2025 | 5:30 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Regeneron Pharmaceuticals is facing a lawsuit with a lead plaintiff deadline of March 10, 2025. Shareholders who incurred losses are advised to explore recovery options under federal securities laws.
The announcement of a lawsuit and a lead plaintiff deadline suggests potential legal challenges for Regeneron, which could negatively impact investor sentiment and stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100